Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 is a synthetic peptide with an arginine and lysine-based sequence, designed for studying receptor binding and signaling pathways. The C-terminal amide improves peptide stability and resistance to enzymatic degradation. Researchers use this analog to investigate peptide-receptor interactions, particularly in the context of neuropeptide signaling and immune modulation.
CAT No: N08006
CAS No:200959-48-4
Synonyms/Alias:Ac-RYYRIK-NH2;200959-48-4;AC-ARG-TYR-TYR-ARG-ILE-LYS-NH2;CHEMBL437723;(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanamide;Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH(2);acetyl-Arg-Tyr-Tyr-Arg-Ile-Lys-NH(2);GTPL1679;BDBM85192;BDBM50190305;AKOS024456481;BA183085;CAS_200959-48-4;L-Lysinamide,N2-acetyl-L-arginyl-L-tyrosyl-L-tyrosyl-L-arginyl-L-isoleucyl-;
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.